Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar;33(2):318-325.
doi: 10.1111/pcmr.12829. Epub 2019 Oct 20.

Evolutionary processes of melanomas from giant congenital melanocytic nevi

Youngkyoung Lim  1 , Hyun-Tae Shin  2 , YoungHwan Choi  1 , Dong-Youn Lee  1
Affiliations
Case Reports

Evolutionary processes of melanomas from giant congenital melanocytic nevi

Youngkyoung Lim et al. Pigment Cell Melanoma Res. 2020 Mar.

Abstract

Melanoma can develop in a congenital melanocytic nevus (CMN). In fact, a large CMN is associated with a high risk of developing melanoma. Although melanomas arising from CMNs are thought to have a pathogenesis distinct from conventional melanomas, no studies have been conducted on the evolution or tumor heterogeneity of CMN melanomas. We applied multi-region whole-exome sequencing to investigate the clonal nature of driver events and evolutionary processes in CMNs and melanomas arising from CMNs. In two patients, we observed an independent subclonal evolution in cancerized fields of CMNs and chromosome 8q amplification in both melanomas arising from CMNs. The amplification of MYC, located in chromosome 8q, was correlated with the percentage of tumor cells expressing high levels of MYC protein detected in melanoma cells by immunohistochemistry. Our analysis suggests that each CMN cell may evolve sporadically and that amplification of MYC might be a key event for melanoma development in CMNs.

Keywords: MYC; Melanoma; congenital melanocytic nevus; evolution; whole-exome sequencing.

PubMed Disclaimer

References

REFERENCES

    1. Andrews, S. (2010). FastQC: A quality control tool for high throughput sequence. Data. https://www.bioinformatics.babraham.ac.uk/projects/fastqc
    1. Bastian, B. C., Xiong, J., Frieden, I. J., Williams, M. L., Chou, P., Busam, K., … LeBoit, P. E. (2002). Genetic changes in neoplasms arising in congenital melanocytic nevi: Differences between nodular proliferations and melanomas. American Journal of Pathology, 161(4), 1163-1169. https://doi.org/10.1016/S0002-9440(10)64393-3
    1. Blancato, J., Singh, B., Liu, A., Liao, D. J., & Dickson, R. B. (2004). Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. British Journal of Cancer, 90(8), 1612-1619. https://doi.org/10.1038/sj.bjc.6601703
    1. Blum, D., Hao, H., McCarthy, M., & Reproducibility Project: Cancer Biology (2015). Registered report: Transcriptional amplification in tumor cells with elevated c-Myc. Elife, 4, https://doi.org/10.7554/eLife.04024
    1. Charbel, C., Fontaine, R. H., Malouf, G. G., Picard, A., Kadlub, N., El-Murr, N., … Guégan, S. (2014). NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. The Journal of Investigative Dermatology, 134(4), 1067-1074. https://doi.org/10.1038/jid.2013.429

Publication types

Substances

Supplementary concepts

LinkOut - more resources